A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study

Paul Ross; Dimitra Repana; M. Saunders; Richard H. Wilson; Christopher J. Plummer; Jennifer Summers; Finola Higgins; Janet Lesley Peacock; D Harari; John Bridgewater

doi:doi.org/10.1016/S0959-8049(17)30306-4

A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study

Paul Ross, Dimitra Repana, M. Saunders, Richard H. Wilson, Christopher J. Plummer, Jennifer Summers, Finola Higgins, Janet Lesley Peacock, D Harari, John Bridgewater

Population Health Sciences

GSTT Guy's and St Thomas' NHS Foundation Trust

Research output: Chapter in Book/Report/Conference proceeding › Poster abstract › peer-review

Original language	English
Title of host publication	European Journal of Cancer
Pages	S69
Volume	72
Edition	Supp 1
DOIs	https://doi.org/doi.org/10.1016/S0959-8049(17)30306-4
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

doi.org/10.1016/S0959-8049(17)30306-4

Cite this

Ross, P., Repana, D., Saunders, M., Wilson, R. H., Plummer, C. J., Summers, J., Higgins, F., Peacock, J. L., Harari, D., & Bridgewater, J. (2017). A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study. In European Journal of Cancer (Supp 1 ed., Vol. 72, pp. S69). Article 487 https://doi.org/doi.org/10.1016/S0959-8049(17)30306-4

@inbook{333bba9d87d94bd3835da1827dc5ff2d,

title = "A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study",

author = "Paul Ross and Dimitra Repana and M. Saunders and Wilson, {Richard H.} and Plummer, {Christopher J.} and Jennifer Summers and Finola Higgins and Peacock, {Janet Lesley} and D Harari and John Bridgewater",

year = "2017",

doi = "doi.org/10.1016/S0959-8049(17)30306-4",

language = "English",

volume = "72",

pages = "S69",

booktitle = "European Journal of Cancer",

edition = "Supp 1",

}

Ross, P, Repana, D, Saunders, M, Wilson, RH, Plummer, CJ, Summers, J, Higgins, F, Peacock, JL, Harari, D & Bridgewater, J 2017, A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study. in European Journal of Cancer. Supp 1 edn, vol. 72, 487, pp. S69. https://doi.org/doi.org/10.1016/S0959-8049(17)30306-4

A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study. / Ross, Paul; Repana, Dimitra; Saunders, M. et al.
European Journal of Cancer. Vol. 72 Supp 1. ed. 2017. p. S69 487.

Research output: Chapter in Book/Report/Conference proceeding › Poster abstract › peer-review

TY - CHAP

T1 - A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study

AU - Ross, Paul

AU - Repana, Dimitra

AU - Saunders, M.

AU - Wilson, Richard H.

AU - Plummer, Christopher J.

AU - Summers, Jennifer

AU - Higgins, Finola

AU - Peacock, Janet Lesley

AU - Harari, D

AU - Bridgewater, John

PY - 2017

Y1 - 2017

U2 - doi.org/10.1016/S0959-8049(17)30306-4

DO - doi.org/10.1016/S0959-8049(17)30306-4

M3 - Poster abstract

VL - 72

SP - S69

BT - European Journal of Cancer

ER -

Ross P, Repana D, Saunders M, Wilson RH, Plummer CJ, Summers J et al. A Phase I/II Dose Finding Study Evaluating The Safety and Tolerability of Capecitabine and Aflibercept in Patients with Unresectable Metastatic Colorectal Cancer Deemed Unsuitable for Doublet/Triplet Chemotherapy: Results of the Phase I Study. In European Journal of Cancer. Supp 1 ed. Vol. 72. 2017. p. S69. 487 doi: doi.org/10.1016/S0959-8049(17)30306-4